MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net gain on realizedcontingent milestone and...$75,137K Trelegy milestoneincome$50,000K Interest and otherincome, net$10,173K (108.42%↑ Y/Y)Collaborative ArrangementRevenue$74,964K Licensing And Milestone$32,500K Income (loss) beforeincome taxes$129,247K (389.70%↑ Y/Y)Loss from operations-$3,602K (92.33%↑ Y/Y)Interest expense(non-cash)$2,461K (-3.34%↓ Y/Y)Total revenues$107,464K (66.92%↑ Y/Y)Net income (loss)$105,895K (287.70%↑ Y/Y)Provision for income taxbenefit (expense)$23,352K (97.83%↑ Y/Y)Total expenses$111,066K (-0.24%↓ Y/Y)Selling, general andadministrative$73,652K (6.47%↑ Y/Y)Research and development$37,414K (-0.61%↓ Y/Y)
Income Statement
source: myfinsight.com

Theravance Biopharma, Inc. (TBPH)

Theravance Biopharma, Inc. (TBPH)